Hyperkalemia in chronic heart failure with renal dysfunction or diabetes mellitus: Results from the TREAT HF study

Código QR

Hyperkalemia in chronic heart failure with renal dysfunction or diabetes mellitus: Results from the TREAT HF study

Guardado en:

Detalles Bibliográficos
Autores principales:	Selda Murat, Hakkı Kaya, Yüksel Çavuşoğlu, Mehmet Birhan Yılmaz
Formato:	article
Lenguaje:	EN TR
Publicado:	KARE Publishing 2021
Materias:	Medicine R Internal medicine RC31-1245 Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/fa2bc761b2c2448fad3a6a23e2d0c5b5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Management of Hyperkalemia in Heart Failure
por: Hakan Altay, et al.
Publicado: (2021)

Hyperkalemia in chronic heart failure
por: Hakan Altay
Publicado: (2021)

Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy
por: Selda Murat, et al.
Publicado: (2021)

Sacubitril/valsartan in real-life clinical practice
por: Yüksel Çavuşoğlu
Publicado: (2021)

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
por: Giuseppe MC Rosano, et al.
Publicado: (2019)

Cardiovascular disintegration: A conceptual, model-based approach to heart failure hemodynamics
por: Emre Aslanger, et al.
Publicado: (2021)

Editorial
por: Hakan Alta, et al.
Publicado: (2021)

Depression in Heart Failure: Psychosomatic Approach
por: Rudi Putranto, et al.
Publicado: (2021)

Resting heart rate and real-life treatment modalities in outpatients with left ventricular systolic dysfunction study: A multicenter, prospective, observational, and national registry
por: Yüksel Çavuşoğlu1, et al.
Publicado: (2021)

Heart Failure 2019 Insights from the National Society of Cardiology journals
por: Plamen Gatzov, et al.
Publicado: (2021)

Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction
por: Ali Çoner, et al.
Publicado: (2021)

Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
por: Berkay Ekici, et al.
Publicado: (2021)

Assessment of ECG during hybrid comprehensive telerehabilitation in heart failure patients—Subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) randomized clinical trial
por: Piotr Orzechowski, et al.
Publicado: (2021)

Acute heart failure in pregnancy: importance of a timely multidisciplinary approach to recognition and management
por: Chacko Sanoj, et al.
Publicado: (2021)

Comparison of clinical features and conventional echocardiographic characteristics of patients with heart failure with mid-range ejection fraction with and without interatrial block
por: Ali Çoner
Publicado: (2021)

Comparison of clinical features and conventional echocardiographic characteristics of patients with heart failure with mid-range ejection fraction with and without interatrial block
por: Mustafa Doğduş, et al.
Publicado: (2021)

Heart failure and diabetes mellitus: insight into comorbidity
por: Nina A. Petunina, et al.
Publicado: (2019)

Impacto pronóstico a corto y largo plazo de la insuficiencia renal en pacientes tratados con angioplastia primaria
por: M. Isabel Barrionuevo Sánchez, et al.
Publicado: (2021)

Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study
por: Michael C. Wang, et al.
Publicado: (2021)

Decompression of the left heart chambers via atrial flow regulator: A new insight into heart failure treatment
por: Uğur Nadir Karakulak, et al.
Publicado: (2021)

Heart bowtie
por: Maryam Shojaeifard, et al.
Publicado: (2021)

Iatrogenic type A aortic dissection during percutaneous coronary intervention: A single-center experience
por: Veysel Özgür Barış, et al.
Publicado: (2021)

Distal transradial angiography
por: Mehmet Fatih Yılmaz, et al.
Publicado: (2021)

Time in therapeutic range among warfarin users in Turkey: Are there enough data to set definitive criteria for reimbursement?
por: Mehmet Akif Topcuoglu,, et al.
Publicado: (2021)

Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
por: James L Januzzi, et al.
Publicado: (2021)

Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure
por: Ahmet Hakan Ateş, et al.
Publicado: (2021)

Development of a novel heart failure risk tool: the barcelona bio-heart failure risk calculator (BCN bio-HF calculator).
por: Josep Lupón, et al.
Publicado: (2014)

Successful therapy of giant right atrial aneurysm accompanying tricuspid valve dysplasia in a child
por: Ahmet Sert, et al.
Publicado: (2021)

The New Heart Failure Association Definition of Advanced Heart Failure
por: Marco Metra, et al.
Publicado: (2019)

The relationship between plasma proadrenomedullin level and severity of the disease in patients with isolated rheumatic mitral stenosis
por: Ali Rıza Demir, et al.
Publicado: (2021)

Association between Markers of Fibrosis and Heart Failure Incidence in Patients with Type 2 Diabetes Mellitus
por: Denis A. Lebedev, et al.
Publicado: (2021)

Hidden in Heart Failure
por: Douglas Ewan Cannie, et al.
Publicado: (2019)

Hyperkalaemia in Heart Failure
por: Umar Ismail, et al.
Publicado: (2021)

The role of brain natriuretic peptide and NT- probrain natriuretic peptide in diagnostics of chronic heart failure and asymptomaticleft ventricular dysfunction in patients with type 2 diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2011)

Aortic floating thrombi with lower limb ischemia and renal infarct in COVID-19: A remote thromboembolic complication
por: Cağdaş Topel, et al.
Publicado: (2021)

Epidemiology of heart failure and long-term follow-up outcomes in a north-African population: Results from the NAtional TUnisian REgistry of Heart Failure (NATURE-HF).
por: Leila Abid, et al.
Publicado: (2021)

Assessment of awareness of risk factors and heart healthy lifestyle as a part of routine cardiovascular evaluation in secondary prevention
por: Meral Kayıkçıoğlu
Publicado: (2021)

The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia
por: Ljiljana Crnobrnja, et al.
Publicado: (2020)

Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway
por: Yan-Bo Sui, et al.
Publicado: (2019)

Glycemic control on development of chronic heart failure in patients with type 2 diabetes mellitus
por: Leonid Grigor'evich Strongin, et al.
Publicado: (2012)